Oscar Health, Inc. (NYSE:OSCR) Insider Sells $117,809.28 in Stock

Oscar Health, Inc. (NYSE:OSCR) insider Mario Schlosser sold 6,516 shares of the stock in a transaction that occurred on Monday, December 2nd. The stock was sold at an average price of $18.08, for a total value of $117,809.28. Following the completion of the sale, the insider now directly owns 81,962 shares of the company’s stock, valued at approximately $1,481,872.96. This trade represents a 7.36 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.

Oscar Health Trading Down 5.7 %

Shares of OSCR stock opened at $16.96 on Thursday. The company has a market cap of $4.19 billion, a price-to-earnings ratio of -282.62 and a beta of 1.63. The firm has a fifty day moving average price of $17.18 and a 200-day moving average price of $17.94. Oscar Health, Inc. has a 1 year low of $7.50 and a 1 year high of $23.79. The company has a debt-to-equity ratio of 0.26, a current ratio of 0.73 and a quick ratio of 0.73.

Oscar Health (NYSE:OSCR) last posted its quarterly earnings data on Thursday, November 7th. The company reported ($0.22) EPS for the quarter, missing the consensus estimate of ($0.20) by ($0.02). The firm had revenue of $2.42 billion for the quarter, compared to analysts’ expectations of $2.33 billion. Oscar Health had a return on equity of 2.79% and a net margin of 0.35%. The firm’s quarterly revenue was up 68.3% compared to the same quarter last year. During the same period in the previous year, the firm earned ($0.29) earnings per share. As a group, equities analysts predict that Oscar Health, Inc. will post -0.01 earnings per share for the current year.

Analyst Ratings Changes

OSCR has been the subject of a number of research analyst reports. UBS Group initiated coverage on Oscar Health in a research report on Monday, October 7th. They set a “neutral” rating and a $23.00 price target for the company. Bank of America lowered Oscar Health from a “neutral” rating to an “underperform” rating and cut their price target for the stock from $21.00 to $13.50 in a report on Wednesday, November 6th. Finally, Piper Sandler reiterated an “overweight” rating and issued a $28.00 price objective on shares of Oscar Health in a research report on Tuesday, September 10th. One investment analyst has rated the stock with a sell rating, two have given a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $22.93.

Hedge Funds Weigh In On Oscar Health

A number of large investors have recently added to or reduced their stakes in OSCR. Wealth Enhancement Advisory Services LLC boosted its position in Oscar Health by 7.5% in the third quarter. Wealth Enhancement Advisory Services LLC now owns 12,028 shares of the company’s stock valued at $255,000 after buying an additional 844 shares during the last quarter. Summit Trail Advisors LLC grew its holdings in shares of Oscar Health by 5.4% during the 2nd quarter. Summit Trail Advisors LLC now owns 20,820 shares of the company’s stock worth $329,000 after purchasing an additional 1,065 shares during the period. KBC Group NV grew its holdings in shares of Oscar Health by 41.2% during the 3rd quarter. KBC Group NV now owns 4,552 shares of the company’s stock worth $97,000 after purchasing an additional 1,328 shares during the period. Arizona State Retirement System boosted its holdings in Oscar Health by 3.7% during the 2nd quarter. Arizona State Retirement System now owns 38,059 shares of the company’s stock valued at $602,000 after acquiring an additional 1,351 shares during the period. Finally, Amalgamated Bank boosted its holdings in Oscar Health by 27.7% during the 2nd quarter. Amalgamated Bank now owns 6,727 shares of the company’s stock valued at $106,000 after acquiring an additional 1,458 shares during the period. 75.70% of the stock is currently owned by institutional investors.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.